Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of valsartan 80 mg capsules under fasting and fed conditions
ChiCTR1800019346Phase 4Recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of valsartan in essential hypertension (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: Cmax, AUC0-t and 4 more. Started Nov 2018; status: recruiting.
02
Drugs
valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on ChiCTR1800019346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019346.